Cargando…
CSCO guidelines for metastatic colorectal cancer: personalized medicine in clinical practice
Autores principales: | Yang, Mengyuan, Xu, Ziheng, Mi, Mi, Ding, Yuwei, Pan, Yuefen, Yuan, Ying, Sun, Weijing, Weng, Shanshan |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Compuscript
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10546093/ https://www.ncbi.nlm.nih.gov/pubmed/37700433 http://dx.doi.org/10.20892/j.issn.2095-3941.2023.0211 |
Ejemplares similares
-
Update in version 2021 of CSCO guidelines for colorectal cancer from version 2020
por: Dong, Caixia, et al.
Publicado: (2021) -
CSCO guidelines for colorectal cancer version 2022: Updates and discussions
por: Yuan, Zhijun, et al.
Publicado: (2022) -
Updates in version 2020 of CSCO guidelines for colorectal cancer from version 2019
por: Weng, Shanshan, et al.
Publicado: (2020) -
Updates in version 2019 of CSCO guidelines for colorectal cancer from version 2018
por: Yuan, Ying, et al.
Publicado: (2019) -
Immunotherapy combined with local therapy in the late-line treatment of repair-proficient (pMMR)/microsatellite stable (MSS) metastatic colorectal cancer
por: Ding, Yuwei, et al.
Publicado: (2023)